Pharmaceutical Cocrystals of Diflunisal and Diclofenac with Theophylline
Citations Over TimeTop 10% of 2014 papers
Abstract
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (DIC) with theophylline (THP) were obtained, and their crystal structures were determined. In both of the crystal structures, molecules form a hydrogen bonded supramolecular unit consisting of a centrosymmetric dimer of THP and two molecules of active pharmaceutical ingredient (API). Crystal lattice energy calculations showed that the packing energy gain of the [DIC + THP] cocrystal is derived mainly from the dispersion energy, which dominates the structures of the cocrystals. The enthalpies of cocrystal formation were estimated by solution calorimetry, and their thermal stability was studied by differential scanning calorimetry. The cocrystals showed an enhancement of apparent solubility compared to the corresponding pure APIs, while the intrinsic dissolution rates are comparable. Both cocrystals demonstrated physical stability upon storing at different relative humidity.
Related Papers
- → A Practical Solid Form Screen Approach To Identify a Pharmaceutical Glutaric Acid Cocrystal for Development(2009)39 cited
- → Diflunisal Targeted Delivery Systems: A Review(2021)22 cited
- → Preparation of Cocrystals of 1,4‐Diimidazolylbutadiene with a Template Molecule and Dependence of the Cocrystal Photochemical Products on Wavelength(2016)6 cited
- → Research Progress of Plant Active Ingredients in Pharmaceutical Cocrystal(2022)4 cited
- Pharmaceutical Co-crystal: A New Paradigm for Enhancing the Physicochemical Properties of Active Pharmaceutical Ingredient(2015)